An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
Clinical trial NCT02911857 · COMPLETED
Trial details
- NCT number
- NCT02911857
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-03
- Primary completion
- 2017-01-27
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.